AJAY JOSEPH

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology TULSA, OK NPI 1104180553

General Payments — all program years on this page

$7,295.98

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 293
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $714.59 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $714.5922

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $18.041
2019 $2,588.5260
2020 $857.8444
2021 $1,307.9276
2022 $1,316.7962
2023 $492.2828
2024 $714.5922

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086977094 Novartis Pharmaceuticals Corporation $28.46 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086977098 Novartis Pharmaceuticals Corporation $28.10 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086977100 Novartis Pharmaceuticals Corporation $34.38 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086977102 Novartis Pharmaceuticals Corporation $17.71 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086977104 Novartis Pharmaceuticals Corporation $30.12 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086977106 Novartis Pharmaceuticals Corporation $20.74 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086977108 Novartis Pharmaceuticals Corporation $29.20 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101738165 E.R. Squibb & Sons, L.L.C. $17.31 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104311562 AstraZeneca Pharmaceuticals LP $26.36 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111611469 Amgen Inc. $14.77 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111611471 Amgen Inc. $15.35 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111611473 Amgen Inc. $15.68 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120655733 Baxter Healthcare $20.06 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132814789 CVRx, Inc. $22.99 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132814791 CVRx, Inc. $22.57 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142213688 ABIOMED $88.53 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142213696 ABIOMED $35.00 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142213738 ABIOMED $35.55 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142213774 ABIOMED $147.29 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142213826 ABIOMED $29.37 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146870362 Philips North America LLC $17.14 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152382502 Kestra Medical Technology Services, Inc. $17.91 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.